Our Training Programs
Our training programs serve a growing need for the training of skilled therapists and mental health professionals who seek to attain advanced skills in the field for future Health Canada-approved psychedelic-assisted psychotherapy practice. We use the term “psychedelic” to refer to the classic and newer psychedelics (Psilocybin, MDMA, LSD, Iboga, Ayahuasca, Ketamine etc.). Participants are health professionals in licensed mental health and medical professions who are seeking to integrate psychedelic medicine and psychedelic-assisted psychotherapy into their clinical practices.
The training program itself is rooted in contemporary medical and mental health research, and also provides the historical foundation from which psychedelic medicines developed. Varied approaches to psychedelic-assisted therapy are presented, including trans-personal psychology, consciousness studies and psychoanalysis, while maintaining a focus on contemporary research and therapy innovation
View our course programs
We believe it is critical and beneficial, from both the client and health care provider perspective, for therapists to gain direct knowledge and an experiential understanding of the effects of psilocybin as psychedelic medicine in order to increase efficacy in the provision of psychedelic-assisted psychotherapies. Our program will provide legal psilocybin experiential and guidance training under a clinical trial umbrella as approved by Health Canada.
*The Introduction to Psychedelic-assisted Therapy is a required course.
This training program will prepare licensed healthcare
professionals to provide psilocybin-assisted therapy to
their clients. Participants will also be offered the
opportunity to enroll in a Phase II Clinical Trial, as and
when approved by Health Canada. The primary
objective of this trial is to document the efficacy
profile of psilocybin in treating general anxiety of
mental healthcare professionals resulting from COVID19. A secondary exploratory objective is to have
participants complete self-assessments on the
psychological outcome of psilocybin. Details on the
trial will be made available when appropriate.
Enrollment begins August 2022
Psilocybin Clinical Trials
Through Health Canada-approved clinical trials, ATMA will work to demonstrate the effectiveness of psilocybin in treating
a variety of mental health indications. From basic safety to efficacy trials, ATMA will answer critical questions
surrounding the use of psilocybin in a clinical setting.
As the COVID-19 pandemic wanes, ATMA’s first priority will be trials focusing on front-line workers who have been
dealing with work-related stress associated with the psychological fallout of the last two years; it will include physicians,
counselors, psychologists, and psychiatrists. Participation in these trials will also provide these mental healthcare
providers the unique opportunity to experience the effects of psilocybin treatment in a safe clinical setting. This first-hand
experience will be useful to therapists for when psilocybin is eventually legalized for psychotherapy.
Get notified about the latest updates
Do I get to experience psilocybin therapy as a participant?
How does the experiential portion of the class work?
What kinds of therapy will this program allow me to offer?
Is there a refund if my situation changes and I can't make the cohort I signed up for?
The ATMA Network
Available with Premium. Recognizing the limited time and resources at your disposal, we provide a turn-key solution to help you incorporate Psychedelic-assisted Therapy in your practice effortlessly. Health professionals who achieve competency in offering this therapeutic intervention will be able to adopt the treatment without any disruptions to current services they provide.
The TNS will allow Psychologists, accredited and certified Counselors and other mental health professionals across Canada to seamlessly integrate Psychedelic-assisted Therapy into clinics and independent practices with the confidence that it is done at a high-level of professionalism and integrity.
First-hand experience and therapist participation in an experiential Practicum Pilot Program
Collaboration, networking and knowledge sharing amongst peers
Be the first to know about upcoming events near you or online
Free updates on the platform
Didactic training, experiential practicums and viable adoption of Psychedelic-assisted Therapy
An intuitive platform that serves both those seeking treatment and Therapy Practitioners wishing to expand